These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 234287)

  • 21. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Renkonen OV
    Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of kitasamycin against gram-positive cocci.
    Balducci Y; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):516-9. PubMed ID: 4156356
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood levels and antibacterial activity of sera in patients treated with cyclacillin.
    Yourassowsky E; Schoutens E; Vanderlinden MP; Butzler JP; Sternon J
    Int J Clin Pharmacol; 1974 Mar; 9(2):120-4. PubMed ID: 4151243
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of antibacterial agents on Haemophilus influenzae isolates.
    Chugh TD; Neil L; Mahboob AG; Araj GF
    Trop Geogr Med; 1986 Dec; 38(4):404-7. PubMed ID: 3492795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
    Sinai R; Hammerberg S; Marks MI; Pai CH
    Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004.
    Daoud Z; Cocozaki A; Hakime N
    Clin Microbiol Infect; 2006 Jan; 12(1):86-90. PubMed ID: 16460553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)].
    Okada J; Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Dec; 28(6):727-39. PubMed ID: 1042183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance patterns of selected respiratory tract pathogens in Poland.
    Skoczyńska A; Kadłubowski M; Waśko I; Fiett J; Hryniewicz W
    Clin Microbiol Infect; 2007 Apr; 13(4):377-83. PubMed ID: 17359321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities.
    Umemura E; Wakiyama Y; Kumura K; Ueda K; Masaki S; Watanabe T; Yamamoto M; Hirai Y; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2013 Mar; 66(3):195-8. PubMed ID: 23232934
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro sensitivity of hemophilus influenzae and streptococcus pyogenes to co-trimoxazole.
    Leers WD
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):59-63. PubMed ID: 1093653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bacteriostatic effect of tetracyclines-macrolides associations].
    de Lajudie P
    Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549
    [No Abstract]   [Full Text] [Related]  

  • 37. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T; Jalanko E; Scheinin L; Renkonen OV
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzae.
    Sanders CC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):843-6. PubMed ID: 6459766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.